# Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer

> **NCT03263520** · NA · COMPLETED · sponsor: **Hospital Erasto Gaertner** · enrollment: 60 (actual)

## Conditions studied

- Cachexia; Cancer

## Interventions

- **DRUG:** Nandrolone Decanoate
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03263520
- **Lead sponsor:** Hospital Erasto Gaertner
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-10-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03263520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03263520, "Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03263520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*